This newly synthesized inhibitor was specific in targeting tumor cells with YY1; however, further developments and studies are necessary to ensure the inhibitor’s effectiveness in in vitro and murine models (Lopez-Perez et al.; unpublished). The gene discussed is YY1; the disease is neoplasm.